Haleon Archives | Cannabiz

Haleon terminates Cann Group agreement following failed S3 trial

by Steve Jones June 15, 2023April 30, 2024

GlaxoSmithKline’s consumer healthcare division, Haleon, has terminated its agreement with Cann Group after the failure of […]

Cann Group prepares for ‘quantum step’ but remains shy on positive cash flow timeframe

by Steve Jones April 18, 2023April 30, 2024

Cann Group to focus on ‘production at scale’ as new CEO beds down

by Steve Jones February 28, 2023April 30, 2024

Cann Group revenue climbs 83% but losses deepen to A$18.8 million

by Steve Jones February 24, 2023April 30, 2024

Cann Group progresses S3 commercial talks with Haleon

by Steve Jones November 7, 2022April 29, 2024

Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale

by Martin Lane October 25, 2022April 29, 2024